Record NNP B-NP O
date NN I-NP O
: : O O
2094-08-12 CD O B-DATE
Patient NNP B-NP O
Name NNP I-NP O
: : O O
HOLDEN,MATIAS NNP B-NP B-PATIENT
[ NNP I-NP O
MRN NNP I-NP O
: : O O
97198841 CD B-NP B-MEDICALRECORD
PGH NNP I-NP B-HOSPITAL
] SYM O O
Date NNP B-NP O
of IN B-PP O
Visit NNP B-NP O
: : O O
08/12/94 CD O B-DATE
Reason NN B-NP O
for IN B-PP O
Visit NNP B-NP O
Return VB B-VP O
visit NN B-NP O
for IN B-PP O
this DT B-NP O
39 CD I-NP B-AGE
m NN I-NP O
with IN B-PP O
hx NN B-NP O
poorly RB B-VP O
controlled VBN I-VP O
DM NNP B-NP O
who WP B-NP O
comes VBZ B-VP O
for IN B-PP O
further JJ B-NP O
mgmt NN I-NP O
of IN B-PP O
DM NNP B-NP O
, , O O
HCV. . O O
History NN B-NP O
of IN B-PP O
Present NNP B-NP O
Illness NNP I-NP O
Decided VBN B-VP O
to TO I-VP O
change VB I-VP O
his PRP$ B-NP O
lantus NN I-NP O
to TO B-VP O
bid VB I-VP O
( -LRB- B-NP O
30 CD I-NP O
u NN I-NP O
bid NN I-NP O
) -RRB- O O
and CC O O
found VBD B-VP O
great JJ B-NP O
response--> JJ I-NP O
bs NNS I-NP O
now RB B-ADVP O
90-120 CD B-NP O
range NN I-NP O
mostly RB B-ADVP O
, , O O
all DT B-NP O
under IN B-PP O
200 CD B-NP O
. . O O
troubled VBN B-VP O
by IN B-PP O
his PRP$ B-NP O
hcv NN I-NP O
infxn NN I-NP O
, , O O
has VBZ B-VP O
been VBN I-VP O
ruminating VBG I-VP O
on IN B-PP O
how WRB B-ADVP O
he PRP B-NP O
got VBD B-VP O
it PRP B-NP O
. . O O
had VBD B-VP O
2 CD B-NP O
episodes NNS I-NP O
needle NN I-NP O
sticks NNS I-NP O
at IN B-PP O
a DT B-NP O
past JJ I-NP O
job NN I-NP O
2+ DT B-NP O
yrs NNS I-NP O
ago RB B-ADVP O
, , O O
wonders NNS B-NP O
if IN B-NP O
could MD B-VP O
have VB I-VP O
gotten VBN I-VP O
then RB B-ADVP O
. . O O
never RB B-ADVP O
used VBD B-VP O
iv FW B-NP O
drugs NNS I-NP O
, , O O
never RB B-ADVP O
had VBD B-VP O
partner NN B-NP O
who WP B-NP O
used VBD B-VP O
iv NN B-NP O
drugs NNS I-NP O
. . O O
reviewed VBN B-VP O
methods NNS B-NP O
of IN B-PP O
transmission NN B-NP O
, , O O
low JJ B-NP O
risk NN I-NP O
of IN B-PP O
sexual JJ B-NP O
transmission NN I-NP O
, , O O
etc FW B-NP O
. . O O
Problems NNS B-NP O
DM . O O
H/O NNP B-NP O
NEPHROLITHIASIS NNPS I-NP O
ANKLE NNP B-NP O
FRACTURE NNP I-NP O
H/O NNP B-NP O
DRUG NNP I-NP O
ABUSE NNP I-NP O
TOBACCO NN B-NP O
WORK NNP B-NP O
# # I-NP O
310-7911 CD I-NP B-PHONE
EXT NNP I-NP O
5 CD I-NP B-PHONE
ROSACEA NN B-NP O
Elevated VBN B-NP O
lipids NNS I-NP O
Microalbuminuria NNP B-NP O
? . O O
migraine . O O
FHX NNP B-NP O
: : O O
M/F/Sis/Bro NNP B-NP O
DM NNP I-NP O
, , O O
F NNP B-NP O
s/p VBD B-VP O
LE JJ B-NP O
amputation NN I-NP O
; : O O
Sis NNP B-NP O
migraines NNS I-NP O
; : O O
no DT B-NP O
CAD/CVA NNP I-NP O
, , O O
no DT B-NP O
htn NN I-NP O
, , O O
no DT B-NP O
prostate/colon NN I-NP O
CA NNP I-NP O
New NNP B-NP O
Phone NNP I-NP O
3/11/94 VBD B-VP B-DATE
: : O O
124-607-0785 CD B-NP B-PHONE
, , O O
work NN B-NP O
485-914-7948 CC O B-PHONE
Allergies . O O
NKA . O O
Medications NNS B-NP O
ECASA NNP B-NP O
( -LRB- I-NP O
ASPIRIN NNP I-NP O
ENTERIC NNP I-NP O
COATED NNP I-NP O
) -RRB- I-NP O
( -LRB- I-NP O
81MG CC O O
TABLET VB B-VP O
EC NNP B-NP O
take VBP B-VP O
1 CD B-NP O
Tablet( NN I-NP O
s VBZ B-VP O
) -RRB- B-NP O
) -RRB- I-NP O
PO NNP I-NP O
QD . O O
* JJ B-NP O
GLUCOSE NNP I-NP O
TEST NNP I-NP O
STRIPS NNP I-NP O
TOPICAL NNP I-NP O
( -LRB- O O
take VB B-VP O
) -RRB- B-NP O
TOP NNP I-NP O
DAILY NNP I-NP O
USE NNP I-NP O
INSULIN NNP B-NP O
SYRINGES NNP I-NP O
FOR IN B-PP O
DAILY NNP B-NP O
( -LRB- O O
take VB B-VP O
) -RRB- B-NP O
TP NNP I-NP O
bid NN I-NP O
and CC O O
prn NN B-NP O
* JJ B-NP O
LANCETS NNS I-NP O
Topical JJ B-NP O
( -LRB- B-VP O
take VB I-VP O
) -RRB- B-VP O
TOP RB I-VP O
daily RB I-VP O
use VB I-VP O
LANTUS NNP B-NP O
( -LRB- I-NP O
INSULIN NN I-NP O
GLARGINE NNP I-NP O
) -RRB- I-NP O
30 CD I-NP O
UNITS NNP I-NP O
SC NNP I-NP O
BID NNP I-NP O
LISINOPRIL NNP B-NP O
10 CD I-NP O
MG NNP I-NP O
PO NNP I-NP O
QD . O O
METFORMIN NNP B-NP O
850 CD I-NP O
MG NNP I-NP O
PO NNP I-NP O
TID NNP I-NP O
PRAVASTATIN NNP B-NP O
( -LRB- B-VP O
40MG VBG I-VP O
TABLET NNP B-NP O
take VB B-VP O
1 CD B-NP O
Tablet( NN I-NP O
s VBZ B-VP O
) -RRB- B-NP O
) -RRB- I-NP O
PO NNP I-NP O
QHS NNS I-NP O
on IN B-PP O
20 CD B-NP O
at IN B-PP O
time NN B-NP O
of IN B-PP O
visit NN B-NP O
Social NNP B-NP O
History NNP I-NP O
Lives NNS B-NP O
with IN B-PP O
GF NNP B-NP O
and CC O O
her PRP$ B-NP O
children NNS I-NP O
. . O O
Is VBZ B-VP O
no DT B-NP O
longer JJR I-NP O
involved VBN B-VP O
with IN B-PP O
ex-wife NN B-NP O
, , O O
who WP B-NP O
is VBZ B-VP O
mother NN B-NP O
of IN B-PP O
his PRP$ B-NP O
children NNS I-NP O
. . O O
From IN B-PP O
Portugal NNP B-NP B-COUNTRY
originally RB B-ADVP O
; : O O
lived VBN B-NP O
in IN B-PP O
OR JJ B-NP B-STATE
for IN B-PP O
18 CD B-NP O
yrs NNS I-NP O
, , O O
in IN B-PP O
palacios NNS B-NP B-CITY
since IN B-PP O
2080 CD B-NP B-DATE
, , O O
plans VBZ B-VP O
to TO I-VP O
stay VB I-VP O
. . O O
Recently RB B-ADVP O
visited VBD B-VP O
father/family NN B-NP O
in IN B-PP O
Portugal NNP B-NP B-COUNTRY
. . O O
Has VBZ O O
dtr NN B-NP O
9 CD I-NP B-AGE
, , I-NP O
son NN I-NP O
11 CD I-NP B-AGE
in IN B-PP O
Portugal NNP B-NP B-COUNTRY
. . I-NP O
Works NNP I-NP O
as IN B-PP O
a DT B-NP O
veterinary JJ I-NP B-PROFESSION
assisstant NN I-NP I-PROFESSION
, , O O
oversees VBZ B-VP O
19 CD B-NP O
clients NNS I-NP O
, , O O
really RB B-ADVP O
likes VBZ B-VP O
it PRP B-NP O
. . O O
Feels NNS B-VP O
he PRP B-NP O
understands VBZ B-VP O
what WP B-NP O
they PRP B-NP O
are VBP B-VP O
going VBG I-VP O
thru VBN I-VP O
from IN B-PP O
his PRP$ B-NP O
own JJ I-NP O
prior JJ I-NP O
experience NN I-NP O
. . O O
Not RB B-ADJP O
happy JJ I-ADJP O
with IN B-PP O
his PRP$ B-NP O
ins NNS I-NP O
plan VBP B-VP O
d/t VBN I-VP O
hi IN B-PP O
copays NNS B-NP O
& CC B-NP O
poor JJ I-NP O
rx NN I-NP O
coverage NN I-NP O
, , O O
but CC O O
his PRP$ B-NP O
employer NN I-NP O
only RB B-ADVP O
offers VBZ B-VP O
one CD B-NP O
plan NN I-NP O
. . O O
No DT B-NP O
etoh NN I-NP O
, , O O
no DT B-NP O
drug NN I-NP O
use NN I-NP O
currently RB B-ADVP O
. . O O
No DT B-NP O
hx NN I-NP O
ivdu NN I-NP O
. . O O
Has VBZ B-VP O
Rx NNP B-NP O
coverage NN I-NP O
, , O O
but CC O O
copays NNS B-NP O
have VBP B-VP O
all DT B-NP O
been VBN I-NP O
increasing VBG I-NP O
. . O O
Vital JJ B-NP O
Signs NNS I-NP O
Blood NN B-NP O
Pressure NN I-NP O
: : O O
105/68 CD B-NP O
Left VBN I-NP O
Arm NN I-NP O
Pulse NNP B-NP O
: : O O
68 CD B-NP O
Regular NNP I-NP O
Weight NNP B-NP O
: : O O
220 CD B-NP O
Pounds NNS I-NP O
Physical NNP B-NP O
Exam NNP I-NP O
Gen NNP B-NP O
: : O O
well RB B-ADVP O
appearing VBG B-VP O
, , O O
NAD NNP B-NP O
, , O O
good JJ B-NP O
spirits NNS I-NP O
. . O O
Impression NN B-NP O
39 CD B-NP B-AGE
m NN I-NP O
with IN B-PP O
poorly RB B-NP O
controlled VBN I-NP O
DM NNP I-NP O
, , O O
albuminuria DT B-NP O
who WP B-NP O
comes VBZ B-VP O
for IN B-PP O
further JJ B-NP O
mgmt NN I-NP O
dm NN I-NP O
and CC O O
with IN B-PP O
recently RB B-NP O
dx VBN I-NP O
'd MD B-VP O
hcv. PRP B-NP O
Over IN B-PP O
1/2 NNP B-NP O
this DT B-NP O
25 CD I-NP O
minute JJ I-NP O
visit NN I-NP O
was VBD B-VP O
spent VBN I-VP O
discussing VBG I-VP O
modes NNS B-NP O
of IN B-PP O
transmission NN B-NP O
of IN B-PP O
hcv NN B-NP O
and CC I-NP O
counseling NN I-NP O
regarding VBG B-VP O
likely JJ B-NP O
etiology/plans NNS I-NP O
for IN B-PP O
bs NNS B-NP O
, , O O
as RB B-CONJP O
well RB I-CONJP O
as IN I-CONJP O
disc NN B-NP O
of IN B-PP O
DM NNP B-NP O
mgmt NN I-NP O
. . O O
Plan NN B-NP O
DM NNP B-NP O
: : O O
a1c NN B-NP O
had VBD B-VP O
come VBN I-VP O
down RB B-ADVP O
from IN B-PP O
11.8-->9.9 CD B-NP O
, , O O
but CC O O
up RB B-ADVP O
to TO B-PP O
10.4 CD B-NP O
last JJ I-NP O
check NN I-NP O
. . O O
now RB B-ADVP O
bs VBZ B-VP O
much RB B-ADVP O
better JJR I-ADVP O
on IN B-PP O
total JJ B-NP O
lantus NN I-NP O
60u IN B-PP O
daily JJ B-NP O
, , I-NP O
split JJ I-NP O
bid NN I-NP O
. . O O
cont VB B-VP O
current JJ B-NP O
regimen NNS I-NP O
, , O O
recheck NN B-NP O
a1c IN B-PP O
next JJ B-NP O
visit NN I-NP O
. . O O
gave VBD B-VP O
# # I-VP O
for IN B-PP O
pt NN B-NP O
to TO B-PP O
r/s NNS B-NP O
f/u VBN B-VP O
with IN B-PP O
optho NNP B-NP O
, , O O
last JJ B-NP O
visit NN I-NP O
spring NN I-NP B-DATE
2093 CD B-NP I-DATE
. . O O
cont NN B-VP O
metformin NN B-NP O
. . O O
had VBD B-VP O
abnl JJ B-NP O
findings NNS I-NP O
w/photos NNS I-NP O
taken VBN B-VP O
on IN B-PP O
dil NN B-NP O
exam NN I-NP O
; : O O
was VBD B-VP O
to TO I-VP O
have VB I-VP O
f/u VBN I-VP O
2/94 CD B-NP B-DATE
but CC O O
did VBD B-VP O
n't RB I-VP O
happen VB I-VP O
. . O O
malb NN B-NP O
elevated VBD B-VP O
97 CD B-NP O
in IN B-PP O
9/93 CD B-NP B-DATE
; : O O
on IN B-PP O
acei NN B-NP O
. . O O
taking VBG B-VP O
asa NN B-NP O
qd NN I-NP O
. . O O
had VBD B-VP O
pneumovax NN B-NP O
2090 CD I-NP B-DATE
. . O O
foot NN B-VP O
exam NN B-NP O
nl NN I-NP O
12/93 CD I-NP B-DATE
. . O O
Albuminuria NNP B-NP O
: : O O
cont NN B-NP O
acei NNS I-NP O
. . O O
last JJ B-NP O
97 CD I-NP O
9/93 CD I-NP B-DATE
. . O O
cr NN B-VP O
stable JJ B-NP O
1.2 CD I-NP O
12/93 CD I-NP B-DATE
. . O O
follow VB B-VP O
cr NN B-NP O
on IN B-PP O
metformin NN B-NP O
. . O O
HCV NNP B-NP O
: : O O
hiv NN B-NP O
was VBD B-VP O
neg JJ B-ADJP O
. . O O
hbv VBD B-VP O
immune JJ B-ADJP O
. . O O
hav VB B-VP O
immune JJ B-ADJP O
. . O O
he PRP B-NP O
had VBD B-VP O
a DT B-NP O
needle NN I-NP O
stick NN I-NP O
around IN B-PP O
june NN B-NP B-DATE
2092 CD I-NP I-DATE
at IN B-PP O
work NN B-NP O
, , O O
was VBD B-VP O
n't RB I-VP O
tested VBN I-VP O
at IN B-PP O
that DT B-NP O
time NN I-NP O
for IN B-PP O
hcv/hiv NN B-NP O
, , O O
but CC O O
had VBD B-VP O
f/u NN B-NP O
test NN I-NP O
( -LRB- I-NP O
for IN B-PP O
hiv NN B-NP O
only JJ I-NP O
apparently RB I-NP O
) -RRB- I-NP O
w/dr NN I-NP O
. . B-NP O
roberson NN I-NP B-DOCTOR
, , O O
neg NN B-NP O
at IN B-PP O
that DT B-NP O
time NN I-NP O
. . O O
discussed VBD B-VP O
that DT B-NP O
hcv NN I-NP O
may MD B-VP O
well RB I-VP O
have VB I-VP O
been VBN I-VP O
from IN B-PP O
needle NN B-NP O
stick NN I-NP O
. . O O
ruq NN B-NP O
u/s NN I-NP O
was VBD B-VP O
nl RB B-ADVP O
, , O O
hcv NN B-NP O
genotype NN I-NP O
1a VBD B-VP O
. . B-NP O
lfts NNS I-NP O
have VBP B-VP O
been VBN I-VP O
consistently RB B-ADJP O
nl RB I-ADJP O
, , O O
last JJ B-NP O
6/94 NN I-NP B-DATE
. . O O
was VBD B-VP O
to TO I-VP O
have VB I-VP O
liver NN B-NP O
bx NN I-NP O
w/dr NN I-NP O
. . O O
kruse NN B-VP B-DOCTOR
in IN B-PP O
april NN B-NP B-DATE
, , O O
but CC O O
never RB B-VP O
occurred VBD I-VP O
. . O O
i PRP B-NP O
will MD B-VP O
contact VB I-VP O
dr NN B-NP O
. . O O
kruse NN B-VP B-DOCTOR
to TO I-VP O
facilitate VB I-VP O
arrangement NN B-NP O
of IN B-PP O
bx NN B-NP O
. . O O
Atypical JJ B-NP O
nevus NN I-NP O
: : O O
dnka NN B-NP O
appt NN I-NP O
w/derm NN I-NP O
for IN B-PP O
eval JJ B-NP O
in IN B-PP O
march NN B-NP B-DATE
. . O O
will MD B-VP O
rerefer VB I-VP O
at IN B-PP O
future JJ B-NP O
visit NN I-NP O
. . O O
copays VBZ B-VP O
$ $ B-NP O
35 CD I-NP O
for IN B-PP O
nonpcp JJ B-NP O
visit NN I-NP O
- : O O
difficult JJ B-NP O
for IN B-PP O
him PRP B-NP O
. . O O
Hyperlipidemia NNP B-NP O
: : O O
has VBZ B-VP O
low JJ B-NP O
hdl NN I-NP O
33 CD I-NP O
in IN B-PP O
6/94 CD B-NP B-DATE
, , O O
reviewed VBN B-NP O
today NN I-NP O
& CC I-NP O
rec'd NN I-NP O
exercise NN I-NP O
. . O O
ldl VBD B-VP O
119 CD B-NP O
on IN B-PP O
pravastatin NN B-NP O
-- : O O
inc NN B-NP O
to TO B-PP O
40 CD B-NP O
mg NN I-NP O
. . O O
lfts NNS B-NP O
nl JJ B-NP O
6/94 CD I-NP B-DATE
. . O O
recheck VB B-VP O
lipids/lfts NNS B-NP O
on IN B-PP O
inc NN B-NP O
prava NN I-NP O
next JJ I-NP O
visit NN I-NP O
. . O O
HM NNP B-NP O
: : O O
lipids NNS B-NP O
as IN B-PP O
above JJ B-NP O
. . O O
had VBD B-VP O
Td NNP B-NP O
booster NN I-NP O
2089 CD B-NP B-DATE
. . B-NP O
re NN I-NP O
: : O O
tob NN B-NP O
cessation/cutting VBG B-VP O
down IN B-PP O
- : O O
he PRP B-NP O
remains VBZ B-VP O
precontemplative JJ B-ADJP O
. . O O
tried VBD B-VP O
wellbutrin RB B-ADVP O
in IN B-PP O
past JJ B-NP O
w/no NN I-NP O
effect NN I-NP O
. . O O
gave VBD B-VP O
him PRP B-NP O
# # B-VP O
for IN B-PP O
pharm NN B-NP O
to TO B-VP O
consider VB I-VP O
Rx NNP B-NP O
assistance NN I-NP O
progs NNS I-NP O
, , O O
as IN B-SBAR O
he PRP B-NP O
has VBZ B-VP O
been VBN I-VP O
interested VBN I-VP O
in IN B-PP O
this DT B-NP O
, , O O
filled VBN B-VP O
out RP B-PRT O
some DT B-NP O
paperwork NN I-NP O
for IN B-PP O
cheaper JJR B-NP O
meds NNS I-NP O
in IN B-PP O
past NN B-NP O
. . O O
also RB B-ADVP O
offered VBD B-VP O
to TO I-VP O
switch VB I-VP O
back RB B-ADVP O
to TO B-VP O
nph VB I-VP O
for IN B-PP O
cost NN B-NP O
reasons NNS I-NP O
today NN B-NP O
, , O O
but CC O O
he PRP B-NP O
declined VBD B-VP O
. . O O
rtc JJ B-NP O
2-3mos JJ I-NP O
f/u NN I-NP O
dm NN I-NP O
, , O O
hcv NN B-NP O
, , O O
check NN B-NP O
lipids/lfts NNS I-NP O
, , O O
umalb NN B-NP O
Kari NNP B-NP B-DOCTOR
Marlene NNP I-NP I-DOCTOR
Pryor NNP I-NP I-DOCTOR
, , O O
M.D. NNP B-NP O
